Balchem CORP (BCPC) 13F Holders & Ownership Data (418 Funds, Q2 2026)

BCPC ranks #1467 out of 37501 tracked stocks by institutional interest — one of the most closely watched names in our coverage.

418 institutions disclose a position in BCPC, but none treat it as a major bet — even Conestoga Capital Advisors, LLC, its most concentrated holder, allocates just 4.0% of its own portfolio to it.

BlackRock has added to its BCPC position for two straight quarters, increasing it by $85.6M to reach $838.7M today.

JPMorgan has trimmed its BCPC position for two straight quarters, cutting it by $20.3M while still holding $58.1M.

BCPC is up 1.2% today, and institutions have been net buyers of $998.1M this quarter — today's price move and the underlying institutional flow are pointing the same direction.

BCPC posted net income of $164.4M over the trailing twelve months.

• Profitable — net income of $164.4M over the trailing twelve months
• Revenue grew 10.1% year over year
• Net income improved year over year, from $142.8M to $164.4M
• Generated $216.6M in positive operating cash flow
• Current ratio of 2.07x — enough short-term assets to cover short-term liabilities
• Liabilities run 0.34x equity — within a conventional range